18
panel
Time Equals Lives: The Evolution of FasterCures
Over the past quarter century, the Milken Institute's FasterCures center has played a central ro
le in accelerating medical solutions.
+ Read More
video
Time Equals Lives: The Evolution of FasterCures
landing page
LeadersLink Program
What is the FasterCures LeadersLink Program?
Established in 2020, the FasterCures LeadersLink Progr
am is a capacity-building program to support the personal development of an emerging cadre o, What Are the Goals of the Program?
The program aims to help promising nonprofit research leaders worldwide build high-performing organizations and facilitate the growth of their peer support network.
+ Read More
landing page
Foundations’ Role in Supporting Clinical Trial Innovation Toolkit
Patient-driven foundations have been playing an increasingly active and important role in supporting
clinical trials as well as the infrastructure to conduct trials in their conditions of interest., Tools You Can Use
Related Resources
+ Read More
article
FasterCures Is Relaunching the TRAIN Newsletter: TRAIN eNews!
Dear TRAIN Friends and Colleagues,
report
Cell and Gene Therapies: Looking Ahead to 2022
Cell and gene therapies are a new category of medicines transforming how we treat and potentially c
ure disease. Both cell and gene therapies seek to modify genetic material to fight disease.
+ Read More
panel
Re-imagining Investment Models in Antibiotics (Invite only)
In partnership with the Wellcome Trust, the Milken Institute's FasterCures and Financial Innovat
ions Lab are examining ways to leverage innovative finance solutions to support the development and commercialization of new antibiotics.
+ Read More
report
A Global Early Warning System for Pandemics: Mobilizing Surveillance for Emerging Pathogens
In 2020, COVID-19 caught the world by surprise—this should not have been the case. The pandemic rev
ealed significant gaps in early warning capabilities to detect and respond to emerging pathogens before they cause global harm.
+ Read More
report
Strengthening the Biomedical Innovation Ecosystem: A Scorecard for System Assessment
As patients, we often evaluate our interactions within the "system" of biomedical innovation with a
simple question: "Did it work for me?" This evaluation considers many issues, including whether the best treatments are accessible and available, how the
+ Read More
panel
Part 1: A Conversation with Rep. Anna Eshoo | Part 2: Unseen Burdens: Managing Chronic Disease During COVID-19 and Beyond
This session will begin with a conversation with US Representative, California, Anna Eshoo follo
wed by a panel discussion.
+ Read More
video
The Drive for More Diverse and Representative Clinical Trials
How can foundations help to drive diverse and representative clinical trials in the face of long s
tanding racial and ethnic disparities in healthcare and research?
+ Read More
video
Master Protocols, Adaptive Designs, and Bayesian Statistics – Oh My
Master Protocols, Adaptive Designs, and Bayesian Statistics: These innovative trial approaches are
sometimes described as being “patient-centric.” Are they? What are the challenges and opportunities for patient groups to support them?
+ Read More